相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Validation of Cell-based Fluorescence Assays: Practice Guidelines from the ICSH and ICCS - Part III - Analytical Issues
Shabnam Tanqri et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Validation of Cell-based Fluorescence Assays: Practice Guidelines from the ICSH and ICCS - Part II - Preanalytical Issues
Bruce H. Davis et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Validation of Cell-based Fluorescence Assays: Practice Guidelines from the ICSH and ICCS - Part V - Assay Performance Criteria
Brent Wood et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Optimal cellular preservation for high dimensional flow cytometric analysis of multicentre trials
Amanda A. P. Ng et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Use of PD biomarkers to drive dose selection and early clinical decision making
Nicola M. Robas
BIOANALYSIS (2012)
Recommendations for the validation of flow cytometric testing during drug development: I instrumentation
Cherie L. Green et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Recommendations for the validation of flow cytometric testing during drug development: II assays
Denise M. O'Hara et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Stability of immunophenotypic markers in fixed peripheral blood for extended analysis using flow cytometry
Cuc Davis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function
Walter C. Olson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Inhibiting the C5-C5a receptor axis
Trent M. Woodruff et al.
MOLECULAR IMMUNOLOGY (2011)
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments
Heleen Scheerens et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Neutrophil function in inflammation and inflammatory diseases
Helen L. Wright et al.
RHEUMATOLOGY (2010)
Neutrophil kinetics in health and disease
Charlotte Summers et al.
TRENDS IN IMMUNOLOGY (2010)
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
G. Wells et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
An Approach to the Validation of Flow Cytometry Methods
Jo Cunliffe et al.
PHARMACEUTICAL RESEARCH (2009)
Chemotactically active proteins of neutrophils
B. K. Pliyev
BIOCHEMISTRY-MOSCOW (2008)
Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2
Hyun Lee et al.
IMMUNOLOGY AND CELL BIOLOGY (2008)
Complement-targeted therapeutics
Daniel Ricklin et al.
NATURE BIOTECHNOLOGY (2007)
Function, structure and therapeutic potential of complement C5a receptors
P. N. Monk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Maintaining the cold chain shipping environment for Phase I clinical trial distribution
MA Elliott et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Evaluation of leukocyte stabilisation in TransFix®-treated blood samples by flow cytometry and transmission electron microscopy
B Canonico et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Reactive oxygen species limit neutrophil life span by activating death receptor signaling
D Scheel-Toellner et al.
BLOOD (2004)
Formalization of the MESF unit of fluorescence intensity
A Schwartz et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2004)
Evaluation of stabilized blood cell products as candidate preparations for quality assessment programs for CD4 T-cell counting
M Bergeron et al.
CYTOMETRY (2002)
分享论文
